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1. Introduction 
The elongation of the growing peptide chain 
during its biosynthesis on the ribosome represents 
a complicated process involving the participation 
of several protein factors contained in the S-100 
supernatant fraction. The mechanism of their action 
is at present intensively investigated [ 1, 21 . This 
study provides evidence showing that tosylphenyl- 
alanyl chloromethane (TPCK, 1-chloro-4-phenyl-3- 
tosyl-amido-2-butanone) is a selective irreversible 
inhibitor of the complex of Sr S3 -factors in the cell- 
free protein-synthetizing system from B. sfearother- 
mophilus. As reported elsewhere, TPCK inhibits 
irreversibly also the T-factor from E. coli [3] . 
2. Xaterials and methods 
14C-L-phenylalanine (103 mCi/mmole) was pur- 
chased from the Institute for Research, Production, 
and Use of Radioisotopes, Prague, CSSR. PolyU and 
TPCK were from Calbiochem, USA, GTP from Koch- 
Light, England, and ATP from Reanal, Hungary. 
Sephadex G-25 Fine was a product of Pharmacia, 
Uppsala, Sweden. 
B. stearothemophilus, strain CCM 2 184 (a gene- 
rous gift of Dr. M. Kocur), was cultivated at 60’ 
with aeration in a medium of the same composition 
as described for E. coli [4] . The cells were harvested 
in the late logarithmic phase of growth, washed [5], 
frozen and then disintegrated by 3-min treatment in 
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a MSE Ultrasonic Generator. The washed ribosomes 
(20 mg/ml) were prepared according to Stenesh et 
al. [6]. The S-100 supernatant (10 mg of protein 
per ml) was prepared according to Algranati and 
Lengyel [5]. The &!&-fraction (i.e. the mixture 
of the St + Ss factor [7]) and the &-factor were 
prepared from the S-100 supernatant by fractiona- 
tion with (NH,), S04, acetone, and chromatography 
on a DEAE-Sephadex column according to a modi- 
fied method of Skoultchi et al. [7]. The details of 
the method will be described elsewhere. The SrSa- 
fraction was identified according to r4C-GTP bind- 
ing [8,9] . The !&-factor was identified on the basis 
of stimulation of the synthesis of polyphenylalanine 
from Phe-tRNA in the presence of the &&-fraction 
and on the basis of ribosome-dependent GTPase ac- 
tivity [lo]. The strict dependence of PolyU direct- 
ed polyphenylalanine formation upon Sr Ss-fraction 
and SZ factor is demonstrated in fig. 1. The Sr Ss- 
fraction (0.75 mg of protein per ml) and the SZ-fac- 
tor (0.3 mg of protein per ml) were stored in a buf- 
fer containing 0.01 M Tris-HCl (pH 7.4) 0.01 M /I- 
mercaptoethanol at 4”. 
The NH4Cl washed ribosomes from E. coli A 19 
(25 mg/ml) were prepared as reported earlier [4]. 
E. coli B tRNA was charged with 14C-phenylalanine 
according to von Ehrenstein and Lipmann [ 1 l] and 
filtered through a Sephadex G-25 column. 
Assay of polyphenylalanine formation. The in- 
corporation mixture contained 0.04 M TrisHCl (pH 
7.4) 0.01 M Mg (CH3C00)2, 0.16 M NH,Cl, 0.008 
M fl-mercaptoethanol, 250 E.cg of E. coli ribosomes, 
North-Holland Publishing Company - Amsterdam 
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Fig. 1. Requirement for Sr SJ and Sa complementary frac- 
tions in polyphenylalanine formation. Effects of increasing 
amounts of St& (a) and Sz (b) on polyphenylalanine syn- 
thesis in the presence of a constant amount of the other com- 
plementary fraction as indicated. The incubation mixture 
contained 104 pmole of 14C-Phe-tRNA and the remaining 
components as shown in Sect. 2. In the absence of St& and 
Ss, 2.5 pmole of phenylalanine was incorporated into hot 
TCA-insoluble precipitate. This amount was subtracted from 
all experimental values. 
20 pg of polyU, 2 mM GTP, 0.5 mM ATP, and 
r4C-Phe-tRNA, the original, control or inhibited 
S-100 (30~1) or SrSa-fraction (301.11) and the Sz- 
factor (10 ~1) as indicated. The total volume of the 
mixture was 0.1 ml. The reaction was started by 
adding GTP. The incubation period was 30 min at 
33’. The reaction was terminated with 5% TCA so- 
lution, and the hot TCA-insoluble material was 
counted in a Frieseke-Hoepfner counter [4]. 
Inhibition by TPCK. One ml of reaction mixture 
cantained: 0.5 mM TPCK, 1 mM GTP, 5% methanol 
and S-100 supematant, or S,Sa-fraction or !&-factor, 
or ribosomes as indicated. The incubation period 
was 3lh hr at 4”. The control sample was incubated 
only with 1 mM GTP and 5% methanol. As “original” 
is considered the sample not preincubated with any 
of the reagents. 
3. Results and discussion 
The preincubation of the S-100 supernatant frac- 
tion from B. steurothemophilus with 5 X 10V4 M 
TPCK leads to an almost complete inhibition of its 
ability to stimulate polyphenylalanine synthesis in 
the cell-free system directed by polyU (table 1). As 
shown, it is not decisive whether the synthesis starts 
Table 1 
Effect of tosylphenylalanyl chloromethane on the activity 
of the S-100 supematant fraction. 
(a) Polyphenylalanine synthesis 
from free phenylalanine (pmoles) 
S-100 supematant 
Original Control Inhibited 
- polyU 5.15 10.7 16.6 
+ polyU 418 365 62.8 
(b) Polyphenylalanine synthesis 
from Phe-tRNA (pmoles) 
- polyU 0.66 0.74 0.44 
+ polyU 30.7 27.1 1.5 
The incubation mixture contained 300 pg of protein of the 
S-100 supematant, buffer, ribosomes, polyU (where indi- 
cated), as given in sect. 2 and in addition in (a) 4 mM ATP, 
0.5 mM GTP, 0.25 PC of “C-phenylalanine, and 200 fig of 
E. coli tRNA, in (b) 92.5 pmole of r4C-Phe-tRNA. The in- 
corporation of phenylalanine into hot TCA-insoluble preci- 
pitate in the absence of S-100 was in (a) 25.3 pmole in the 
absence of polyU and 16.6 pmole in the presence of polyU, 
in (b) 4.2 pmole in the absence of poly U and 4.07 pmole in 
the presence of polyU. These amounts were subtracted from 
the corresponding experimental values. 
Table 2 
The irreversibility of the inhibitory effect of tosylphenyl- 
alanyl chloromethane on the S-100 supernatant fraction. 
Polyphenylalanine synthesis (pmoles) 
S-100 supernatant 
Original Control Inhibited 
Before 
Sephadex column 29.8 
After 
Sephadex column - 
28.1 2.12 
23.1 0.8 
150 ~1 of the control or inhibited S-100 fraction was filtered 
through 1.2 ml of Sephadex G-25 Fine in 0.02 M Tris-HCl 
buffer (pH 7.8), 0.01 M Mg (CHsCOO)a, 0.01 M p-mercapto- 
ethanol, and 5% methanol. 30 11 of the peak fraction of the 
control or inhibited S-100 fraction was used in the experi- 
ment after the filtration. The incubation mixture contained 
74 pmole of 14C-Phe-tRNA and the remaining components 
as given in sect. 2. The incorporation of phenylalanine into 
hot TCA-insoluble precipitate in the absence of S-100 super- 
natant was 3.28 pmole. This amount was subtracted from all 
experimental values. 
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Table 3 
The effect of tosylphenylalanyl chloromethane on the indk 
vidual components of the protein-synthesizing system. 
Polyphenylalanine synthesis (pmoles) 
Fraction treated Original Control Inhibited 
(a) S1 S3 
(b) Ribosomes 




22.3 20.85 20.5 
20 15.2 16.1 
E. coli + S2 22.3 17.24 16.2 
(e) Ribosomes B. stea- 
rothermophilus 72.5 66.3 63 
The incubation mixture contained in (a) to (d) 22.5 /.rg of 
protein of the Sr Ss-fraction, 3 rg of protein of the S2-fac- 
tor, in (e) 125 c(g of protein of the S-100 fraction and 200 
pg of ribosomes from B. stearothermophilus, and further 
104 pmole of 14C-PhetRNA and the remaining components 
as given in sect. 2. The incorporation of phenylalanine into 
hot TCA-insoluble precipitate was 2.54 pmole in the ab- 
sence of all factors [(a), (c)], 0.24 pmole in the absence of 
ribosomes [(b), (d), (e)] , and these quantities were subtract- 
ed from all the corresponding experimental values. 
from free phenylalanine or from phenylalanyl-tRNA. 
In the first case the incorporation of phenylalanine 
is inhibited by 83%, in the second case even by 95%. 
This result also indicates that the process in phenyl- 
alanine synthesis affected by TPCK is not the syn- 
thesis of Phe-tRNA but that TPCK interferes with 
the subsequent reactions which take place during 
the de nova synthesis after aminoacyl-tRNA had 
been formed. 
The observed inhibitory effect of TPCK on the 
S- 100 supernatant system is most likely irreversible 
as follows from the results given in table 2. The fil- 
tration of the inhibited S-100 fraction through a 
Sephadex G-25 column in order to remove unreact- 
ed TPCK does not change the incorporation activity 
of this fraction. 
In other experiments we tested the effect of 
TPCK on the individual components of protein-syn- 
thetizing system, that is on the ribosomes from E. 
coli and B. stearothennophilus, on the Si S3 -fraction, 
and on the &-factor. The results given in table 3 pro- 
vide convincing evidence showing that it is the S1S3- 
fraction which is unambiguously and primarily affect- 
ed by the action of TPCK. The activity of neither 
the S2 -factor nor of the ribosomes from E. coli or 
from B. stearothetmophilus are influenced by this 
inhibitor under the conditions which lead to an in- 
hibition of the S1S3fraction by TPCK by 92%. 
Till now TPCK has been known as an effective 
inhibitor of certain proteolytic enzymes [ 121. The 
observation of its inhibitory effect on the SlS3 -frac- 
tion or the T-factor [3] during protein synthesis is 
thus surprising. A detailed elucidation of the mecha- 
nism of its effect in the process of synthesis of a 
new peptide on the ribosome will be the subject of 
our further studies. 
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